Regeneron Pharmaceuticals will release its second-quarter earnings next month, and analysts anticipate a double-digit profit ...

Merck has had a successful track record of beating estimates, having surpassed EPS expectations 88% of the time and beating ...

The market expects Regeneron (REGN) to deliver a year-over-year decline in earnings on lower revenues when it reports results ...

Regeneron Pharmaceuticals is on the cusp of unveiling its Q2 2025 earnings this Friday, with expectations pinned at $8.53 per share and a revenue forecast of $3.30 billion. Analysts are eyeing a ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the most profitable biotech stocks to invest in now. Canaccord ...

Earnings season begins this week. With the tariff overhang and higher expectations for coming quarters, forward earnings guidance from management will be crucial.

Cincinnati, Ohio-based The Kroger Co. (KR) operates as a food retailer in the United States. With a market cap of $47.2 ...

Constellation Brands (NYSE: STZ) is scheduled to announce Q1 earnings results on Tuesday, July 1st, after market close.

26 analysts have shared their evaluations of Regeneron Pharmaceuticals REGN during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find a ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Regeneron Pharmaceuticals. Looking at options history for Regeneron Pharmaceuticals REGN we detected 14 trades. If we ...